Lobbying Information
Subject Matters
- Budget
- Economic Development
- Health
- Research and Development
- Science and Technology
Subject Matter Details
Policies or Program, Regulation
- Federal government relations and advocacy regarding regulations under the Patented Medicine Prices Review Board (and its impact to drugs for rare diseases), national pharmacare policy and implementation, and the development of a federal strategy for drugs for rare diseases.
Build awareness with decision makers on ADHD, the lack of broad-based screening, and advocate for the implementation of programs to improve diagnosis and support of those living with ADHD.
Educate decision makers on the 2015 Canadian Consensus Framework for Ethical Collaboration and support a review with stakeholders.
Communication Techniques
-
Written communication
-
Oral communication
-
Grass-roots communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Canadian Institutes of Health Research (CIHR)
-
Correctional Service of Canada (CSC)
-
Finance Canada (FIN)
-
Health Canada (HC)
-
House of Commons
-
Indigenous Services Canada (ISC)
-
Innovation, Science and Economic Development Canada (ISED)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Safety Canada (PS)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
22 Adelaide Street West
Suite 3800
Toronto, ON M5H 4E3
Canada
Telephone number:
647-798-2200
Web address:
https://www.takeda.com/en-ca/
Client representative
Rebecca Yu, Vice President, Market Access and External Affairs
Parent Company Information
Takeda Canada Inc. is not a subsidiary of any other parent companies.
Coalition Members Information
Takeda Canada Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Takeda Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Takeda Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Patil Imasdounian
|
No public offices held
Business address:
1 Nicholas Street, Suite 414
Ottawa, ON K1N 7B7
Canada
Telephone number:
647-530-8501
Consultant Firm and Address
Firm:
Santis Health
Address:
1 Nicholas Street, Suite 414
Ottawa, ON K1N 7B7
Canada
Telephone number:
855-485-8451
